HSPG2 and neoplasm: The phenotypes of the cells treated with FZD4 siRNAs were similar to those of Sja-miR-71a mimics-treated cells, suggesting that the FZD4 be the target gene of Sja-miR-71a and mediated anti-tumor effects.